Connecticut Peptide Fulfillment
Connecticut sterile compounders: reach patients directly through Script Unlock's transparent bidding marketplace. Bid on peptide, GLP-1, HRT, PT-141, and other 503A patient-specific prescriptions in your state.
Why Now: The 2026 Peptide Reclassification
The February 27, 2026 HHS announcement signaled that approximately 14 peptides — including BPC-157, TB-500, CJC-1295, Ipamorelin, Sermorelin, GHK-Cu, and Thymosin Alpha-1 — are expected to return to Category 1 status. The FDA Pharmacy Compounding Advisory Committee reviewed seven peptides on July 23–24, 2026 and recommended six for the 503A Bulks List.
The demand is coming. Patients who turned to the gray market from 2023–2026 want to return to licensed pharmacies. Sterile compounders in Connecticut that position early capture the wave.
Read the full reclassification timelineWhy Connecticut Compounders Use Script Unlock
Set your own cash price per prescription. Patients see transparent bids from verified compounders. No PBM clawbacks, no DIR fees.
Weight-loss, HRT, peptide, and PT-141 patients actively search Script Unlock for Connecticutcompounders. Get in front of Rx demand you can already fulfill.
Script Unlock displays your USP 797 certification, PCAB accreditation, and Connecticut State Board of Pharmacy license status to patients transparently. Trust as a competitive advantage.
Flat platform fee. No per-Rx transaction cut, no hidden fees. Cancel anytime. Universal pricing — no chain tier, no volume discount.
Patient-specific 503A compounders and FDA-registered 503B outsourcing facilities are both eligible. List your capability, bid on prescriptions that match.
Script Unlock is built for independent Connecticut pharmacies. Chains do not receive priority placement — patient choice is the ranking signal.
Rx Categories You Can Bid On
Compounded semaglutide (during FDA shortage windows), tirzepatide (503A patient-specific), liraglutide. Highest patient search volume in Connecticut.
BPC-157, TB-500, CJC-1295, Ipamorelin, Sermorelin, GHK-Cu injectable, Thymosin Alpha-1 — once formal FDA reclassification is published. Get positioned now.
Estradiol, progesterone, testosterone — patient-specific dose forms. High-margin, high-repeat category.
FDA-approved as Vyleesi; compounded for individualised dosing under 503A patient-specific prescriptions.
Ready to bid on Connecticut peptide prescriptions?
$149/month. No PBM friction. Independent-friendly.
Script Unlock is a patient-pharmacy bidding marketplace, not a pharmacy. All pharmacies in the Connecticut network are independently licensed by Connecticut State Board of Pharmacy. Pricing is set by pharmacies, not Script Unlock.